ArticleJournal of molecular histology2025
Renoprotective effect of diosmin against chlorpyrifos-induced kidney injury is mediated by the regulation of TLR4/HMGB1/NF-κB, PPAR-γ/SIRT1, and Bax/Bcl2 signals.
Article in Journal of molecular histology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Evidence-Based Assessment of Pesticide-Related Nephrotoxicity: Clinical Outcomes, Experimental Data, and Molecular Signatures.International journal of molecular sciences · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chlorpyrifos, an organophosphorus pesticide commonly used in agriculture, has been associated with nephrotoxicity and other harmful effects. This study investigates the renoprotective effects of diosmin, a flavonoid known for its antioxidant and anti-inflammatory properties, against chlorpyrifos-induced kidney damage in rats. Male Wistar albino rats were exposed to chlorpyrifos at a dose of 10 mg/kg for 28 days, and the protective role of diosmin at a dose of 50 mg/kg, orally, was assessed through various biochemical, histopathological, molecular, and computational analyses. Chlorpyrifos exposure significantly induced kidney damage by elevation of kidney functions and NGAL, as well as histopathological alteration. In addition, chlorpyrifos exposure induced renal inflammation as evidenced by upregulation of TLR4, HMGB1, p-NF-κB, TNF-α, IL-1β, and MPO levels. Besides, chlorpyrifos induced oxidative stress as evidenced by decreasing PPAR-γ, SIRT1, GSH, and SOD expressions associated with increased MDA levels. Furthermore, chlorpyrifos induced renal cell apoptosis, as proved by Bax and Bcl2 dysregulation. Interestingly, co-administration of diosmin with chlorpyrifos ameliorated these effects, restoring kidney function biomarkers, preserving histological structure, suppressing inflammatory burden, reducing oxidative stress parameters, and inhibiting apoptosis. In addition, the results of molecular docking confirmed the in vivo results. Taken together, diosmin exerts a renoprotective effect by attenuating chlorpyrifos-induced oxidative stress and inflammation, highlighting its potential as a therapeutic agent for mitigating pesticide-induced kidney injury.
Indexed as
Identifiers
41361550What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.